Study identifies unique subgroup of women with SUI
April 1st 2007Among women with stress incontinence and no signs of detrusor overactivity, there exists a significant subgroup with low voided volumes, high incidences of urgency and urge-related leaks, and relatively severe symptoms that can only be identified through careful evaluation.
New nerve stim approach may provide option in OAB
April 1st 2007Dorsal genital nerve stimulation using a minimally invasive, pre-pubic approach appears to reduce the symptoms of overactive bladder and is well tolerated by patients, according to results of a prospective, multicenter feasibility study.
PBS/IC incidence, causes: Studies offer some clues
April 1st 2007Exactly what painful bladder syndrome/interstitial cystitis is, how many people have it, what the risk factors are, what its causes are, what its natural history is, and how it differs from other types of voiding dysfunction in men are questions still looking for answers.
Expectations guide patients' view of incontinence treatment
April 1st 2007Urinary incontinence patients' personal goals and expectations are more closely tied to their quality of life than is any objective measure of the disease, suggesting that treatment outcomes should be assessed in a more patient-focused manner.
Biomarker changes may predict bladder cancer outcomes
April 1st 2007Assessment of a set of four apoptosis markers in patients with urothelial-cell carcinoma of the bladder appears helpful for predicting which patients are at elevated risk for disease recurrence and disease-specific mortality after radical cystectomy and bilateral lymphadenectomy.
Experts strive to comprehend IC: What's in a name?
April 1st 2007Bethesda, MD-Concepts of what interstitial cystitis is, what causes it, and how to treat it are changing. That was apparent with the tremendous infusion of new ideas from many specialties here at the 2006 International Symposium: Frontiers in Painful Bladder Syndrome and Interstitial Cystitis, sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases. Whether those concepts can change without changing the name of the disease, however, was a hotly debated question.
Bill would create federal Office of Men’s Health
March 15th 2007Rep. Vito Fossella (R-NY) has proposed federal legislation to create an Office of Men’s Health that would promote research of male-specific medical issues and educate men on how to improve their health. If passed, the new office would be housed in the federal Department of Health and Human Services.
Cryo may be as effective as laparoscopic removal for kidney tumors
March 15th 2007Percutaneous cryoablation of kidney tumors may be as effective as laparoscopy in eligible patients, according to research presented at the Society of Interventional Radiology’s 32nd annual scientific meeting in Seattle.
False-positive PSA results lead to excess worry, sexual dysfunction
March 15th 2007Men with prostate cancer screenings that result in false-positive results are approximately three times as likely to indicate some degree of concern about developing prostate cancer, and are nearly twice as likely to experience impaired sexual function, compared with men with normal results, new research from the University of Iowa, Iowa City, shows.
Seeds vs. prostatectomy: Long- and short-term side effects differ slightly
March 15th 2007For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
ED after prostate cancer treatment may be underreported
March 1st 2007Las Vegas-Researchers don't agree on how to measure erectile function and dysfunction, making it difficult to determine the effects of prostate cancer treatment on patients' sex lives, said Johns Hopkins researchers who presented a review of 592 articles at the Sexual Medicine Society of North America fall meeting here.
Peyronie's: Researchers give nod to autologous grafts
March 1st 2007Las Vegas- In their first experiences with xenografts for Peyronie's disease, surgeons at the Mayo Clinic in Jacksonville, FL, decided that Surgisis (Cook Biotech Incorporated, West Lafayette, IN) worked better than Tutoplast (IOP, Inc., Costa Mesa, CA), but the surgeons said they still prefer autologous grafts.
PSA screening rates soar beyond guideline limits
March 1st 2007San Francisco-AUA's recommendation that PSA screening for prostate cancer be avoided in men with an anticipated life expectancy of less than 10 years appears to be a guideline more honored in the breach, according to a study from the San Francisco VA Medical Center published in JAMA (2006; 296:2336-42).
PSA doubling time: When is it useful as a treatment guide?
March 1st 2007PSA doubling time is an accepted tool to determine the probability that prostate cancer will or will not be clinically significant following primary treatment. However, the definition and proper use of PSA doubling time in clinical practice has become controversial. In this interview, W. Scott McDougal, MD, discusses where the controversy lies and explains when and how this measurement can (and cannot) be used to guide treatment decisions. Dr. McDougal is chief of the department of urology at Massachusetts General Hospital and professor of urology at Harvard Medical School, Boston. He was interviewed by former Urology Times Editorial Consultant Robert C. Flanigan, MD, who is professor and chairman of the department of urology, Loyola University, Maywood, IL.